Latest Articles

Publication Date
Endometriosis and risk factors in pregnancy, labor and delivery: a case-control study.

It is a common thought that endometriosis and its related pain symptoms could improve during pregnancy. However, endometriosis was shown to affect the regular development of pregnancy and delivery outcomes. …

Published: Nov. 8, 2024, midnight
Soluble adhesion molecules in serum and peritoneal fluid are associated with pelvic pain in endometriosis.

To investigate the association between soluble adhesion molecules (sE-cadherin, sE-selectin, sICAM-1, sVCAM-1) in serum and peritoneal fluid and pelvic pain in infertile women with endometriosis.

Published: Nov. 8, 2024, midnight
Associations between stigma and depression among college-attending women with endometriosis symptoms.

Background: Endometriosis is a debilitating and highly stigmatized chronic condition. The relationship between stigma and depressive symptoms among college-attending women with endometriosis symptoms was examined. Method: Data were analyzed from …

Published: Nov. 8, 2024, midnight
Intraoperative dual laparoscopy and neo-rectoscopy for precise excision of bowel endometriosis.

Published: Nov. 8, 2024, midnight
The crucial component(s) of Guizhi Fuling Wan in inhibiting endometriosis development.

Endometriosis is a common gynecological disorder that manifests as chronic pelvic pain and subfertility. Guizhi Fuling Wan (GFW), which contains five herbs, was first described in Chinese canonical medicine to …

Published: Nov. 8, 2024, midnight
Surgical treatment of endometriosis - Controversies: Preface.

Published: Nov. 8, 2024, midnight
Mesenchymal stem cells: Guardians of women's health.

Mesenchymal stem cells (MSCs) have attracted more and more attention because of their multidirectional differentiation potential, immune regulatory abilities and self-renewal capacity. In recent years, their use has become prominent …

Published: Nov. 8, 2024, midnight
Efficacy and safety of estetrol (15 mg)/drospirenone (3 mg) combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: a multicenter, placebo-controlled, double-blind, randomized study.

To evaluate the efficacy and safety of the estetrol (E4) (15 mg)/drospirenone (DRSP) (3 mg) combination in a cyclic regimen in Japanese women with primary and secondary dysmenorrhea.

Published: Nov. 8, 2024, midnight
Holistic approaches to living well with endometriosis.

Endometriosis is a common chronic non curable neuro-inflammatory condition, which can cause endometriosis-related pelvic pain (ERPP). Sufferers may struggle with side effects and/or risks from conventional medical and surgical treatments, …

Published: Nov. 8, 2024, midnight
Dr Powell on the Implications of the FDA Approval of Dostarlimab for Endometrial Cancer - OncLive

Dr Powell on the Implications of the FDA Approval of Dostarlimab for Endometrial Cancer OncLive

Published: Nov. 7, 2024, 8:04 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!